September 8, 8:43 AM
Chardan Capital analyst Matthew Barcus initiates coverage on Purple Biotech (NASDAQ:PPBT) with a Buy rating and announces Price Target of $11.
July 21, 5:54 PM
Gainers Hanger (NYSE:HNGR) stock moved upwards by 27.1% to $18.75 during Thursday's after-market session. The company's market cap stands at $731.7 million.
May 26, 6:13 PM
March 25, 6:43 AM
Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares gained 39.1% to close at $1.05 on Thursday. The company recently said its CFO Bruce Colwill will retire.
March 8, 5:47 PM
Purple Biotech Announces Initiation Of Part 2 Of Ongoing Phase 1/2 Clinical Trial Evaluating NT219 For Treatment Of Multiple Cancers Supporting Potential Expansion Of Clinical Program
December 6, 8:33 AM
Purple Biotech (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective and durable therapies by overcoming tumor immune evasion and drug resistance, today announced the initiation of Part 2 of